Last data update: 24 January 2024 16:39 CET
Plasmid name: pCAGGS-E-mMyD88 (LMBP 6654)
New search | Print data sheet |
Price category: | Cat. 1 (cf. price list) |
Status: | GeneCorner core plasmid |
GeneCorner sequence: |
p6654.gb
(View with Genome Compiler) p6654.txt p6654.pdf |
Sequence analysis results Genecorner: |
- |
Cloned DNA: |
Mouse myeloid differentiation primary response gene 88 cDNA (Myd88, GeneID 17874) E-tag; N-terminal |
Promoter: | Chicken β-actin/rabbit β-globin hybrid promoter (AG) Human cytomegalovirus immediate early promoter (CMV-IE); enhancer only Escherichia coli lac operon promoter |
Ribosome binding site: |
- |
Terminator: | Rabbit β-globin polyadenylation signal (β-globin polyA) Simian virus 40 polyadenylation signal (SV40 polyA) |
Selection marker: | Ampicillin (amp) |
Replicon: | Escherichia coli plasmid pMB1 origin Simian virus 40 bidirectional origin (SV40) |
Host range: | Escherichia coli Mammalian cells; SV40 permissive cells |
Parental clone: | pCAGGS-E-mMyD88 |
Further information: | The plasmid was constructed as follows: 1) the 3' end of mouse Myd88 cDNA was PCR amplified from pCAGGS-E-mMyD88, reinserting the termination codon and reconstructing the unique BglII site; 2) this PCR fragment was ligated as an MscI/BglII fragment into the MscI/BglII opened pCAGGS-E-mMyD88 vector. The latter vector contains mouse MyD88 cDNA that was picked up from the mouse macrophage cell line Mf4/4 and fused in frame to the E-tag of a pCAGGS-based expression plasmid; however, the termination codon seemed to be missing. This plasmid is useful for highly efficient expression of mouse MyD88 under the control of the AG promoter and the human CMV-IE enhancer in various mammalian cells. When cloning a fragment downstream from the lac promoter it may be advisable to use lacI(q) strains in order to prevent fortuitous expression of a possibly noxious polypeptide. The nucleotide sequence of this plasmid corresponds with the EMBL Nucleotide Sequence Database accession number LT726837.1. The nucleotide sequence of the mouse Myd88 cDNA corresponds with the EMBL Nucleotide Sequence Database accession number U84409.1. Name mentioned in Maelfait et al. (2008) is pCAGGS-E-MyD88. Other name of the plasmid is pCAGGS-E-mMyD88-2. |
EMBL Accession number: | U84409.1, view at EMBL, GenBank, DDBJ LT726837.1, view at EMBL, GenBank, DDBJ |
Latest sequence update: | 11/03/2009 |
Sequence detail: | Primers used to amplify and reconstruct the 3' end of mouse Myd88: Forward: 5' - CAG.GTG.GCC.AGA.GTG.GAA.AG MscI Reverse: 5' - ATCTAGATCT.TCA.GGG.CAG.GGA.CAA.AGC.CTT.GG BglII +++ +++: termination codon. Punctuation indicates reading frame. |
Authenticity test: | Restriction enzyme pattern analysed at GeneCorner: BamHI, BglII, BstZI, EcoRV and NcoI. |
Class: | Recombinant plasmid |
Type: | Plasmid |
History of deposit: | This plasmid was deposited by Dr S. Janssens(1) (2) and Prof. Dr R. Beyaert(1) (2). (1) Department for Molecular Biomedical Research, VIB, Ghent, Belgium (2) Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium |
Plasmid reference: | - |
Related plasmid reference: | Maelfait et al., J. Exp. Med. 205 (2008), 1967-1973 [PMID: 18725521] [DOI: 10.1084/jem.20071632] Janssens et al., FEBS Lett. 548 (2003), 103-107 [PMID: 12885415] Janssens et al., Trends Biochem. Sci. 27 (2002), 474-482 [PMID: 12217523] Janssens et al., Curr. Biol. 12 (2002), 467-471 [PMID: 11909531] |
Restricted distribution: | - BCCM MTA |
Distributed as: | H/P active culture or plasmid DNA |
Host for distribution: | Escherichia coli K12 MC1061 |
Host reference: | Casadaban et al., J. Mol. Biol. 138 (1980), 179-207 [PMID: 6997493] |
Related host reference: | Brigé et al., Biochem. J. 394 (2006), 335-344 [PMID: 16293111] |
Cultivation medium: | LB-Lennox + ampicillin (100 μg/ml) |
Cultivation temperature: | 37°C |
Biosafety level: | L1 |
Cultivation remark: | - |
Other culture collection numbers: | LMBP 05645 |
Refer in your Materials and Methods: |
pCAGGS-E-mMyD88 (LMBP 6654) is available at BCCM/GeneCorner. This plasmid was deposited by Dr S. Janssens and Prof. Dr R. Beyaert . |
Note: Up-to-date, validated data are enclosed with the biological material. Nevertheless, these data are a snapshot at a given moment; further updates are always possible.